Over the past 20 years intravenous feeding has become a standard form of nutritional support for sick infants. Although the indications for its use in preterm neonates may be poorly defined, there is no doubt that parenteral nutrition has transformed the prognosis for newborns when severe congenital or acquired bowel disease precludes enteral feeding.'
Synthetic crystalline L-amino acid solutions such as Vamin (KabiVitrum), which is based on the amino acid profile of egg protein, have commonly been used as the nitrogen source for parenterally fed children, although they were originally designed for adults. Compared with breast milk (table 1) , this results in overprovision of some amino acids (such as phenylalanine) but underprovision of others (such as taurine) that are now considered essential for patients on long term parenteral nutrition. 2 An additional consideration is that, in contrast to older patients, the most appropriate profile of amino acids administered to newborn infants may not only be different but much less flexible. The need for growth means that the young infant Glycine   75  48  83  Proline  288  180  222  Valine  153  130  143  Threonine  107  87  143  Lysine  139  135  222   Serine   267  81  151  Glutamic acid  320  337  282  Leucine  189  180  278  Taurine  0  9  13  Histidine   85  46  83   Arginine   117  73  163   Tyrosine   18  57  20   Phenylalanine   196  72  108  Isoleucine  139  100  123   Cystine   50  37  40   Tryptophan  36  45  56  Methionine  68  28  52   Aspartic acid  146  165  163 Egg and breast milk based nitrogen sources compared 1473 requires relatively larger quantities of essential amino acids than an older child or adult. Furthermore, immaturity of enzyme systems in the neonatal liver may reduce the capability for synthesis and catabolism of certain amino acids. For example, liver cystathionase activity is low at full term, and endogenous synthesis of cystine from methionine is limited, making cystine an essential amino acid in the neonate. In addition, although histidine is not considered essential for adults, it seems to be required for normal growth in newborn infants.3
We recently showed that plasma amino acid profiles in babies fed with a conventional amino acid source often show increased concentrations of potentially neurotoxic 6phenylalanine.4 Others have shared our concern,5 and debate continues over the optimum composition of parenteral feeding solutions.7 Attempts have been made to design amino acid preparations suited to the particular requirements of newborn infants, in some instances with the aim of producing a plasma amino acid profile during parenteral feeding that is similar to that found in breast fed babies. Total parenteral nutrition was prescribed for all patients in accordance with a standard protocol and administered by central venous catheter.9 Intakes/ kg body weight were progressively increased over the first six days of feeding and then maintained at constant amounts as follows: carbohydrate, 8 g, 10 g, 10 g, 12 g, 12 g, 14 g; amino acids, 0-5 g, 1 0 g, 1.5 g, 2-0 g, 2-5 g; fat, 1 g, 2 g, 2 g, 3 g, 3 g, 3.5 g. The maximum daily energy intake was therefore 0-41 MJ/kg. Detailed records of intravenous infusions including additional peripheral infusions were kept so that precise calculation of intakes of fluid, electrolytes, and nutritional components could be made.
ANTHROPOMETRY
Patients were weighed daily to the nearest 10 g using electronic scales (Seca). Additional anthropometric measurements were made on day 0 and day 6 by a single experienced observer; head circumference was measured to the nearest 0-1 cm using a paper tape measure, and triceps and subscapular skinfold thickness to the nearest 0.2 mm with skin calipers (Holtain Ltd).
HAEMATOLOGrCAL AND BIOCHEMICAL MONITORING Infusion of Intralipid was suspended at 5 am each morning until venous blood from a peripheral vein was sampled, between 9 and 10 am. Vamin was constantly infused through the central venous feeding catheter and was not interrupted before the peripheral blood was sampled. Blood was taken on the day after the maximum intake of nutrients was reached (day 0) and then 72 and 144 hours later. In addition to plasma amino acid profile, estimation of sodium, potassium, creatinine, albumin, total bilirubin, calcium, phosphate, magnesium, glucose, and haemoglobin concentrations, full blood count, and alanine aminotransferase and y glutamyltranspeptidase activities were also carried out. Plasma for amino acid analysis was deproteinised by addition of an equal volume of 3% sulphosalicylic acid immediately after collection. The supernatant was then stored at -20°C until analysis. Plasma concentrations were measured with a Kontron Chromakon 500 amino acid analyser using a lithium buffer system and ninhydrin detection. collected during the final 72 hours of the study for subsequent analysis of nitrogen content. During this period patients were nursed on a metabolic bed placed inside an incubator.'0 Urine, nasogastric aspirate, and ileostomy specimens were stored at 4°C until the 72 hour collection was completed. As subjects received no enteral feed during the study, stool losses from the rectum were minimal and were ignored. Specimens were homogenised, total volume measured, and then 20 ml aliquots stored at -20°C until analysis. Nitrogen content was determined using the micro Kjeldahl method'1 and phenol-hypochlorite (Bertholet) There are several reasons why plasma amino acid profiles in patients given Vaminolact still differ from those in breast fed infants. An intravenous amino acid intake of 2-5 g/kg/day is 25% higher than with breast milk of average composition. Furthermore, plasma amino acid profiles in breast fed infants reflect modification of relative amino acid concentrations during small intestinal absorption and subsequent passage of portal blood through the liver. That such modification occurs is one reason why attempts to reproduce those plasma amino acid profiles found in breast fed infants exactly in parenterally fed infants are probably misguided.
The mean tyrosine concentration in infants fed Vamin 9 glucose was also high compared with that reported in breast fed infants,12 and tyrosine concentrations were significantly higher than those found in the Varmiinolact group (p=0-0004). This too is a cause for concern, as it has been suggested that raised tyrosine concentrations may be related to long term developmental impairment. 16 The raised tyrosine concentrations probably reflect phenylalanine catabolism, as the intake of tyrosine with both Vamin 9 glucose and Vaminolact is similar. The low mean concentration of tyrosine found in the Vaminolact group suggests possible underprovision of this amino acid, which is said to be 'semiessential' in the very low birthweight infant. This might pose problems in long term parenteral nutrition, although the consequences of a low tyrosine intake are unknown.
The increased threonine concentrations with Vaminolact reflect the fact that intake of threonine is about 50% higher than in the Vamin 9 glucose or breast fed infants, but does not exceed the recommended maximum for preterm infants.17 Although concentrations of cystine/cysteine were low, clinical studies have shown that cystine deficient diets have no apparent adverse effects on growth or nitrogen balance in preterm infants and the precise requirements for cystine remain unknown.18 19 The implications of the hyperphenylalaninaemia observed in the Vamin 9 glucose group are difficult to assess. Recent 
